[HTML][HTML] Blood–brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia

B Hussain, C Fang, J Chang - Frontiers in neuroscience, 2021 - frontiersin.org
The blood–brain barrier (BBB) plays a vital role in maintaining the specialized
microenvironment of the neural tissue. It separates the peripheral circulatory system from the …

A new era for understanding amyloid structures and disease

MG Iadanza, MP Jackson, EW Hewitt… - … reviews Molecular cell …, 2018 - nature.com
The aggregation of proteins into amyloid fibrils and their deposition into plaques and
intracellular inclusions is the hallmark of amyloid disease. The accumulation and deposition …

Religious orders study and rush memory and aging project

DA Bennett, AS Buchman, PA Boyle… - Journal of …, 2018 - content.iospress.com
Background: The Religious Orders Study and Rush Memory and Aging Project are both
ongoing longitudinal clinical-pathologic cohort studies of aging and Alzheimer's disease …

Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model

A Kingston, L Robinson, H Booth, M Knapp… - Age and …, 2018 - academic.oup.com
Background models projecting future disease burden have focussed on one or two
diseases. Little is known on how risk factors of younger cohorts will play out in the future …

[HTML][HTML] Nanotechnology: a promising approach for delivery of neuroprotective drugs

S Naqvi, A Panghal, SJS Flora - Frontiers in Neuroscience, 2020 - frontiersin.org
Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …

Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions

A Abeysinghe, R Deshapriya, C Udawatte - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most
common cause for dementia. Despite huge global economic burden and the impact on the …

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

S Norton, FE Matthews, DE Barnes, K Yaffe… - The Lancet …, 2014 - thelancet.com
Background Recent estimates suggesting that over half of Alzheimer's disease burden
worldwide might be attributed to potentially modifiable risk factors do not take into account …

[HTML][HTML] Drug treatments in Alzheimer's disease

R Briggs, SP Kennelly, D O'Neill - Clinical medicine, 2016 - Elsevier
Despite the significant public health issue that it poses, only five medical treatments have
been approved for Alzheimer's disease (AD) and these act to control symptoms rather than …

A clinicopathological approach to the diagnosis of dementia

FM Elahi, BL Miller - Nature Reviews Neurology, 2017 - nature.com
The most definitive classification systems for dementia are based on the underlying
pathology which, in turn, is categorized largely according to the observed accumulation of …

The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia

VI Reus, LJ Fochtmann, AE Eyler… - American Journal of …, 2016 - Am Psychiatric Assoc
The goal of this guideline is to improve the care of patients with dementia who are exhibiting
agitation or psychosis. More specifically, this guideline focuses on the judicious use of …